CNS Organoid Neuropharmacological Analysis
Posted
Apr 24, 2026
Due Date
May 4, 2026
Description
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=27ffc4f12c804e68a7146718582955b6
AI Summary
The U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) is conducting market research to assess the availability of small‑business sources capable of performing CNS organoid neuropharmacological analysis. The effort, classified under NAICS 541380 (Testing Laboratories and Services) with a $19 million small‑business size standard, seeks capability statements that demonstrate the ability to supply U.S.–made products/services, meet Section 508 accessibility standards (including an Accessibility Conformance Report based on the Voluntary Product Accessibility Template 2.0), and provide three years of past‑performance data for comparable work. Respondents must identify applicable GSA Schedule numbers, SINs, Best‑in‑Class or AbilityOne contracts, and disclose business details (SAM ID, size status, contact information, warranty terms, place of manufacture/performance, and any subcontracting opportunities for small businesses). All required deliverables—including electronic raw and analyzed data for 32 organoids per group across ten treatment groups (time points pre‑exposure and Days 3, 5, 7, 12, 14) and transcriptomic data for 40 datasets on Day 14—must be provided in electronic format, with data use limited to contract performance and governed by the contract’s data‑rights clauses. The period of performance is 8/1/2026 through 3/31/2027 on a firm‑fixed‑price basis, with work performed at the contractor’s facility and no government‑furnished property, security, or travel requirements. Responses are due by 13:00 CT on May 4, 2026, via email to nick.sartain@fda.hhs.gov (Reference NCTR‑2026‑13 4171). This notice is for market‑research purposes only and does not obligate the Government to award a contract; however, the information provided will inform future solicitation decisions, including potential small‑business set‑aside or open‑competition awards. All submissions must avoid proprietary, classified, or sensitive information, and any public disclosure of non‑public data requires prior written approval from the Contracting Officer.
Details
- Notice ID
- 27ffc4f12c804e68a7146718582955b6
- Solicitation Number
- NCTR-2026-134171
- NAICS Code
- 541380
- Classification Code
- B537
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- FDA Scientific & Regulatory Support Services(SRS)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS
- Cross Connection Hazard Assessment
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA DISTRIBUTION.DLA DISTRIBUTION
- B533--VANIHCS SPS Water Testing (VA-27-00000760)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.250-NETWORK CONTRACT OFFICE 10 (36C250)
- H365--ANNUAL MEDICAL GAS TESTING POP: 12/01/2026 - 09/30/2031
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.262-NETWORK CONTRACT OFFICE 22 (36C262)
- USNS KAISER (T-187 Ultrasonic Gauging Hull Special Survey 8)
DEPT OF DEFENSE.DEPT OF THE NAVY.MSC.MSFSC.MILITARY SEALIFT COMMAND BATS
- A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.CENTERS FOR DISEASE CONTROL AND PREVENTION.CDC OFFICE OF ACQUISITION SERVICES
- TDA Isolated Phase Bus and Duct Inspection
DEPT OF DEFENSE.DEPT OF THE ARMY.US ARMY CORPS OF ENGINEERS.ENGINEER DIVISION NORTHWESTERN.ENDIST PORTLAND.W071 ENDIST PORTLAND
- Sample Analysis -Maurepas cyanotoxin analysis
INTERIOR, DEPARTMENT OF THE.DEPARTMENTAL OFFICES.USGS CONTRACTING ACTIVITY